(Q33238884)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Rainer Voisard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mustafa Alan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Regine Baur

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Vinzenz Hombach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

4 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

BMC Cardiovascular Disorders

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

19 January 2020

copyright license

start time

7 July 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2261-6-32

0 references

cites work

A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Platelet GPIIb/IIIa antagonists: the first anti-integrin receptor therapeutics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

A Factor from a Transformed Cell Line That Affects Cell Migration

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

GPIIb-IIIa: the responsive integrin

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Adhesion receptors of the immune system

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Intracoronary brachytherapy--clinical state and pathophysiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

"Edge Effect" of (32)p radioactive stents is caused by the combination of chronic stent injury and radioactive dose falloff

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Rationale for coronary artery radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Intravascular brachytherapy: a review of the current vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Intercellular adhesion molecule-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Mononuclear cell adhesion and cell adhesion molecule liberation after X-irradiation of activated endothelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Effect of abciximab-coated stent on in-stent intimal hyperplasia in human coronary arteries.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Inflammation as a therapeutic target: a unique role for abciximab

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Decrease of vascular smooth muscle cell locomotion by abciximab, but not tirofiban: a possible role of different affinity to alpha v beta 3 integrins

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Leukocyte attack in a 3D human coronary in-vitro model

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Beta3-integrins rather than beta1-integrins dominate integrin-matrix interactions involved in postinjury smooth muscle cell migration.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and the extracellular matrix.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Relative roles of ICAM-1 and VCAM-1 in the pathogenesis of experimental radiation-induced intestinal inflammation

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-32

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1475639

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Migratory activity of human smooth muscle cells cultivated from coronary and peripheral primary and restenotic lesions removed by percutaneous atherectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

In vitro growth characteristics of human atherosclerotic plaque cells: comparison of cells from primary stenosing and restenosing lesions of peripheral and coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Pharmacodynamics of abciximab during angioplasty: comparison to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Serum levels of circulating adhesion molecules after coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

A role for intercellular adhesion molecule-1 in restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during n

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Reduced intimal thickening following alpha(v)beta3 blockade is associated with smooth muscle cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Vitaxin, a humanized monoclonal antibody to the vitronectin receptor (alphavbeta3), reduces neointimal hyperplasia and total vessel area after balloon injury in hypercholesterolemic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

Abciximab Inhibits the Migration and Invasion Potential of Human Coronary Artery Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2261-6-14

21 January 2018

Identifiers

DOI

10.1186/1471-2261-6-32

1 reference

http://europepmc.org/abstract/PMC/1475639

15 July 2018

10.1186/1471-2261-6-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16595000%20AND%20SRC:MED&resulttype=core&format=json